MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Etiology and Pathogenesis"

  • 2018 International Congress

    Apolipoprotein E and multiple system atrophy

    K. Ogaki, Y. Martens, M. Heckman, S. Koga, L. Labbé, O. Lorenzo-Betancor, A. Wernick, R. Walton, A. Soto, E. Vargas, H. Nielsen, S. Fujioka, T. Kanekiyo, R. Uitti, J. van Gerpen, W. Cheshire, Z. Wszolek, P. Low, W. Singer, N. Hattori, D. Dickson, G. Bu, O. Ross (Tokyo, Japan)

    Objective: This study evaluated genetic associations of Apolipoprotein E alleles with risk of multiple system atrophy (MSA) and α-synuclein pathology, and also examined whether apolipoprotein…
  • 2018 International Congress

    Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

    G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by loss of dopamine neurons in the substantia nigra. We measured neuroinflammatory marker fractalkine in…
  • 2018 International Congress

    PROMESA: A randomised, double-blind, placebo-controlled trial to evaluate the progression rate of MSA under EGCG supplementation as anti-aggregation-approach

    J. Levin, S. Maass, M. Schuberth, A. Giese, W. Oertel, W. Poewe, C. Trenkwalder, G. Wenning, U. Mansmann, M. Suedmeyer, K. Eggert, B. Mollenhauer, A. Lipp, M. Loehle, J. Classen, A. Muenchau, J. Kassubeck, G. Ebersbach, D. Berg, S. Egert, C. Eberhardt, F. Paul, K. Boetzel, B. Ertl-Wagner, H. Huppertz, I. Ricard, G. Hoeglinger (Munich, Germany)

    Objective: To evaluate the safety and tolerability of epigallocatechin gallate (EGCG) in high doses and its efficacy to slow down disease progression in patients with…
  • 2018 International Congress

    Effects of mannitol treatment in a mice model of multiple system atrophy (MSA)

    N. Lev, Y. Barhum (Kfar Saba, Israel)

    Objective: The aim of this study was to examine the effect of mannitol treatment in a mice model of MSA. Background: Alpha-synuclein aggregation represents the…
  • 2018 International Congress

    Expanding the NINDS Parkinson’s Disease Biomarkers Program – Utilizing a Major Biomarker Resource to Address Atypical Parkinsonisms and Related Conditions

    C. Lungu, K. Arce, D. Babcock, K. David, BA. Sieber, C. Swanson-Fischer, M. Sutherland (Rockville, MD, USA)

    Objective: Expansion of a carefully curated resource for clinical and biosample data to address a critical need for biomarker discovery in Atypical Parkinsonisms and related…
  • 2018 International Congress

    Immunological causes of atypical parkinsonism

    M. Cesarini, J. Etcheverry, G. Da Prat, G. Rojas, N. Gonzalez Rojas, E. Gatto (La Plata, Argentina)

    Objective: To study the clinical and biochemical features of atypical parkinsonism. Evaluate results of the immune-mediated treatment Background: Atypical parkinsonism is a heterogeneous group of…
  • 2018 International Congress

    Cerebrospinal fluid levels of cytokines in multiple system atrophy: A cross-sectional study of the atalan msa registry (CMSAR)

    Y. Compta, S. Dias, M. Pulido-Salgado, D. Giraldo, A. Pérez-Soriano, M. Fernández, A. Cámara, P. Bravo, E. Muñoz, J. Saura, MJ. Marti (Barcelona, Spain)

    Objective: To compare the cerebrospinal fluid (CSF) levels of 38 cytokines in multiple system atrophy (MSA) patients vs. control and Parkinson’s disease (PD) subjects. Background:…
  • 2017 International Congress

    Gut Microbiota in Multiple System Atrophy

    A.H. Tan, C.W. Chong, S.-L. Song, C.S.-J. Teh, I.K.-S. Yap, M.F. Loke, Y.Q. Tan, H.S. Yong, S. Mahadeva, A.E. Lang, S.-Y. Lim (Kuala Lumpur, Malaysia)

    Objective: To investigate the gut microbiome and metabolome in MSA Background: Experimental models of prion-like cell-to-cell transfer of alpha-synuclein(AS) and its ability to spread from the…
  • 2017 International Congress

    Evaluation of mitochondrial dysfunction in fibroblasts and iPSC-derived dopaminergic neurons of patients affected by Multiple System Atrophy

    G. Monzio Compagnoni, E. Frattini, F. Fortunato, D. Ronchi, A. Bordoni, M. Garbellini, S. Salani, M. Guida, N. Bresolin, S. Corti, G.P. Comi, A. Di Fonzo (Milano, Italy)

    Objective: The aim of the present study is to investigate mitochondrial functioning in fibroblasts and iPSC-derived dopaminergic neurons of patients affected by Multiple System Atrophy…
  • 2017 International Congress

    Are a „mathematical brain“ and early childhood adverse events possible risk factors that contribute to Progressive Supranuclear Palsy?

    S. Lorenzl (Hausham, Germany)

    Objective: To evaluate possible risk factors for the development of Progressive Supranuclear Palsy (PSP). Background: Risk factors for the development of neurodegenerative brain disorders are…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley